HHLR ADVISORS, LTD. - Q2 2020 holdings

$10.9 Billion is the total value of HHLR ADVISORS, LTD.'s 74 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 36.7% .

 Value Shares↓ Weighting
ZM BuyZOOM VIDEO COMMUNICATIONS INcl a$1,738,519,000
+92.1%
6,856,980
+10.7%
15.89%
+30.3%
IQ  IQIYI INCsponsored ads$1,082,848,000
+30.3%
46,694,6290.0%9.90%
-11.6%
BGNE  BEIGENE LTDsponsored adr$1,030,974,000
+53.0%
5,472,2590.0%9.42%
+3.8%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$847,720,000
+120.2%
3,930,086
+98.5%
7.75%
+49.3%
PDD BuyPINDUODUO INCsponsored ads$846,714,000
+169.2%
9,863,866
+13.0%
7.74%
+82.6%
UBER  UBER TECHNOLOGIES INC$598,623,000
+11.3%
19,260,7000.0%5.47%
-24.5%
TAL BuyTAL EDUCATION GROUPsponsored ads$540,615,000
+35.2%
7,906,041
+5.3%
4.94%
-8.3%
JD SellJD.COM INCspon adr cl a$470,030,000
-2.5%
7,810,402
-34.4%
4.30%
-33.9%
BILI SellBILIBILI INCspons ads rep z$421,608,000
+76.2%
9,102,063
-10.9%
3.85%
+19.5%
CBPO BuyCHINA BIOLOGIC PRODS HLDGS I$302,665,000
+1.9%
2,962,076
+7.7%
2.77%
-30.9%
ESGR  ENSTAR GROUP LIMITED$267,018,000
-3.9%
1,747,8400.0%2.44%
-34.9%
ALGN SellALIGN TECHNOLOGY INC$216,908,000
+16.9%
790,365
-25.9%
1.98%
-20.7%
APLS  APELLIS PHARMACEUTICALS INC$164,224,000
+21.9%
5,028,2890.0%1.50%
-17.3%
FGEN  FIBROGEN INC$160,328,000
+16.6%
3,955,7870.0%1.47%
-20.9%
BBIO  BRIDGEBIO PHARMA INC$153,645,000
+12.4%
4,711,6040.0%1.40%
-23.7%
TSLA  TESLA INC$140,783,000
+106.1%
130,3780.0%1.29%
+39.7%
CRM BuySALESFORCE COM INC$132,910,000
+67.7%
709,495
+28.9%
1.22%
+13.8%
ZTO  ZTO EXPRESS CAYMAN INCsponsored ads a$126,047,000
+38.6%
3,433,5920.0%1.15%
-6.0%
MDLZ SellMONDELEZ INTL INCcl a$124,305,000
-2.5%
2,431,164
-4.5%
1.14%
-33.9%
VIE SellVIELA BIO INC$121,983,000
-30.1%
2,815,868
-38.7%
1.12%
-52.6%
VIPS SellVIPSHOP HOLDINGS LIMITEDsponsored ads a$109,055,000
-0.6%
5,477,392
-22.3%
1.00%
-32.6%
BPMC SellBLUEPRINT MEDICINES CORP$106,441,000
+12.8%
1,364,631
-15.4%
0.97%
-23.5%
ARGX BuyARGENX SEsponsored adr$105,858,000
+1507.1%
470,000
+840.0%
0.97%
+987.6%
GOSS BuyGOSSAMER BIO INC$96,473,000
+60.8%
7,420,974
+25.5%
0.88%
+9.0%
BEAM  BEAM THERAPEUTICS INCcl a$83,059,000
+55.6%
2,966,4030.0%0.76%
+5.4%
MYOK SellMYOKARDIA INC$66,731,000
+45.8%
690,658
-29.2%
0.61%
-1.1%
SE SellSEA LTDsponsored ads$64,182,000
+15.9%
598,489
-52.1%
0.59%
-21.3%
TSM NewTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$62,475,0001,100,495
+100.0%
0.57%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$62,269,000
+112.2%
2,443,833
+28.9%
0.57%
+43.7%
GMAB  GENMAB A/Ssponsored ads$50,835,000
+59.9%
1,500,0000.0%0.46%
+8.6%
OTIS NewOTIS WORLDWIDE CORP$34,944,000614,556
+100.0%
0.32%
ALLO NewALLOGENE THERAPEUTICS INC$34,256,000800,000
+100.0%
0.31%
LN SellLINE CORPsponsored adr$33,858,000
-19.3%
676,211
-22.4%
0.31%
-45.3%
ZLAB SellZAI LAB LTDadr$32,852,000
+15.6%
400,000
-27.6%
0.30%
-21.7%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$31,328,000
+16.8%
3,985,7970.0%0.29%
-21.0%
LEGN NewLEGEND BIOTECH CORPsponsored ads$27,664,000650,000
+100.0%
0.25%
NVAX NewNOVAVAX INC$27,175,000326,038
+100.0%
0.25%
MLCO SellMELCO RESORT ENTMNT LTDadr$26,367,000
-3.3%
1,698,877
-22.7%
0.24%
-34.3%
AKRO BuyAKERO THERAPEUTICS INC$26,332,000
+39.4%
1,056,673
+18.6%
0.24%
-5.5%
IGMS  IGM BIOSCIENCES INC$25,550,000
+30.0%
350,0000.0%0.23%
-11.7%
AMG BuyAFFILIATED MANAGERS GROUP IN$24,983,000
+37.8%
335,073
+9.3%
0.23%
-6.6%
ADCT NewADC THERAPEUTICS SA$23,405,000500,000
+100.0%
0.21%
FMTX NewFORMA THERAPEUTICS HLDGS INC$23,245,000500,000
+100.0%
0.21%
GTHX  G1 THERAPEUTICS INC$23,033,000
+120.1%
949,4310.0%0.21%
+49.6%
YY NewJOYY INC$21,206,000239,476
+100.0%
0.19%
ARVN SellARVINAS INC$20,963,000
-39.2%
625,000
-26.9%
0.19%
-58.7%
MOGU  MOGU INCspon ads$18,805,000
+57.2%
10,446,9700.0%0.17%
+6.8%
RGNX  REGENXBIO INC$16,794,000
+13.7%
456,0000.0%0.15%
-22.6%
RCUS SellARCUS BIOSCIENCES INC$15,463,000
+45.2%
625,000
-18.5%
0.14%
-2.1%
NXTC SellNEXTCURE INC$13,685,000
-65.0%
638,307
-39.4%
0.12%
-76.2%
RNA NewAVIDITY BIOSCIENCES INC$12,011,000425,000
+100.0%
0.11%
GRUB  GRUBHUB INC$11,908,000
+72.6%
169,3860.0%0.11%
+17.2%
HOOK  HOOKIPA PHARMA INC$10,961,000
+40.9%
943,2540.0%0.10%
-4.8%
BNR NewBURNING ROCK BIOTECH LTDsponsored ads$10,804,000400,000
+100.0%
0.10%
MRUS  MERUS N V$9,654,000
+33.0%
600,0000.0%0.09%
-10.2%
EIDX  EIDOS THERAPEUTICS INC$8,514,000
-2.7%
178,6000.0%0.08%
-33.9%
CALT NewCALLIDITAS THERAPEUTICS ABsponsered ads$8,155,000350,000
+100.0%
0.08%
LPTX NewLEAP THERAPEUTICS INC$7,532,0003,604,040
+100.0%
0.07%
SOHU  SOHU COM LTDsponsored ads$7,387,000
+47.8%
802,0340.0%0.07%
+1.5%
PASG  PASSAGE BIO INC$6,849,000
+73.5%
250,6160.0%0.06%
+18.9%
TXG  10X GENOMICS INC$6,698,000
+43.3%
75,0000.0%0.06%
-3.2%
CJJD  CHINA JO-JO DRUGSTORES INC$6,679,000
-23.8%
4,840,0000.0%0.06%
-48.3%
KDP NewKEURIG DR PEPPER INC$6,008,000211,556
+100.0%
0.06%
GDS NewGDS HLDGS LTDsponsored ads$5,313,00066,700
+100.0%
0.05%
TCRR  TCR2 THERAPEUTICS INC$4,960,000
+98.5%
322,9030.0%0.04%
+32.4%
HTHT NewHUAZHU GROUP LTDsponsored ads$4,514,000128,786
+100.0%
0.04%
UXIN SellUXIN LTDads$4,285,000
-61.6%
2,996,543
-58.6%
0.04%
-74.0%
CBMG  CELLULAR BIOMEDICINE GROUP I$3,521,000
-5.4%
235,2140.0%0.03%
-36.0%
CVET  COVETRUS INC$2,775,000
+119.7%
155,1240.0%0.02%
+47.1%
API NewAGORA INCads$1,327,00030,050
+100.0%
0.01%
CIH  CHINA INDEX HLDGS LTDspnsrd ads a$642,000
+58.5%
300,0000.0%0.01%
+20.0%
NEW  PUXIN LTDads$651,000
+20.6%
126,1450.0%0.01%
-14.3%
MREO NewMEREO BIOPHARMA GROUP PLCads$382,000124,970
+100.0%
0.00%
SFUN NewFANG HLDGS LTDadr new$340,00030,000
+100.0%
0.00%
SFUN ExitFANG HLDGS LTDadr new$0-300,000
-100.0%
-0.01%
NVDA ExitNVIDIA CORP$0-50,000
-100.0%
-0.18%
SDC ExitSMILEDIRECTCLUB INC$0-2,898,086
-100.0%
-0.18%
SNAP ExitSNAP INCcl a$0-4,465,885
-100.0%
-0.72%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings